脊髓电刺激装置扩展MRI认证对制造商建议依从性的影响
该回顾性亚组分析研究Proclaim®脊髓电刺激装置扩展MRI认证是否使更多MRI检查符合制造商建议,分析了62例次MRI扫描。结果显示新旧认证下仅略超50%的植入系统获准MRI检查,新认证下更高比吸收率时符合建议的扫描数显著增加(p=0.011),但第一时段未达统计学显著(p=0.078),无装置相关不良事件。
要点
- 仅略超50%的植入系统获准MRI检查,新旧认证无显著改善。
- 新认证扩展了电极放置选项,但未显著增加MR条件兼容装置数量。
- 更高比吸收率下,第二时段符合建议的扫描数显著增加(p=0.011)。
核心结论
- 新MRI认证适合在制造商规范内执行更多扫描;颈段电极仍存在问题,因需要更长电极且较低阻抗抑制MRI模式。
研究设计与样本
- 回顾性亚组分析,分析Proclaim®植入式脉冲发生器患者的全部MRI检查技术数据及医疗数据,按2019年前后两个时段分别分析。
关键影像表现/征象
- 共识别62例次带植入式脉冲发生器的MRI扫描。
- 无论新旧认证,仅略超50%的病例整个植入系统获准MRI检查。
- 新认证扩展了电极放置选项,但未显著改善MR条件兼容装置的数量。
- 更高比吸收率时,第二时段符合建议的扫描数显著更多(p=0.011)。
- 第一时段符合建议的扫描数未达统计学显著(p=0.078)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The current approval for all available spinal cord stimulation (SCS) devices set several limitations for magnetic resonance imaging (MRI). As a result, most of the necessary examinations are not possible within the scope of the restrictive approvals and, if legally permitted, must be carried out off-label. This retrospective subgroup analysis investigates if the currently extended MRI approval of one specific device allows more MRI scans to be conducted within the manufacturer's recommendations.
MATERIALS AND METHODS: Technical MRI data (saved in the DICOM headers) and medical treatment data for all MRI examinations on patients with Proclaim® implantable pulse generators (IPG; Proclaim® spinal cord stimulation systems, Abbott Laboratories, Plano, TX, USA) were examined. Due to a major change in our standard operating procedures for MRI scans in 2019, the two time periods (before and after 2019) were separately analyzed.
RESULTS: We identified 62 MRI scans with the IPG. The entire implanted system was approved for MRI examinations in just over 50% of the cases, regardless of old and new approval. Options for lead placement were expanded in the new approval; however, this did not significantly improve the number of MR conditional devices. By contrast, for a higher specific absorption rate, significantly more scans within the recommendations are possible in Period 2 (p = 0.011). However, the number of possible scans did not reach statistical significance in Period 1 (p = 0.078). No device-related adverse events were noted.
CONCLUSION: The new MRI approval is suitable for performing more scans within the manufacturer's specifications. Cervical leads remain problematic because longer leads are required, and the lower impedances inhibit the MRI mode.
引用
- Reining M, Winkler D, Kirchhof K, et al. Effects of an extended MRI approval of an implantable spinal cord stimulation device on compliance with manufacturer's recommendations. Pain Pract. 2025. PMID: 40159636. doi:10.1111/papr.70022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。